Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

VEGF-B inhibitor

DRUG CLASS:

VEGF-B inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

ziv-aflibercept IV (4)

ziv-aflibercept IV (4)

›

No biomarker	Colorectal Cancer	No biomarker	Colorectal Cancer	ziv-aflibercept IV Sensitive: A1 - Approval ziv-aflibercept IV Sensitive : A1	ziv-aflibercept IV Sensitive: A1 - Approval ziv-aflibercept IV Sensitive : A1
No biomarker	Rectal Cancer	No biomarker	Rectal Cancer	ziv-aflibercept IV Sensitive: A2 - Guideline ziv-aflibercept IV Sensitive : A2	ziv-aflibercept IV Sensitive: A2 - Guideline ziv-aflibercept IV Sensitive : A2
No biomarker	Colon Cancer	No biomarker	Colon Cancer	ziv-aflibercept IV Sensitive: A2 - Guideline ziv-aflibercept IV Sensitive : A2	ziv-aflibercept IV Sensitive: A2 - Guideline ziv-aflibercept IV Sensitive : A2
BRAF mutation	Colorectal Cancer	BRAF mutation	Colorectal Cancer	ziv-aflibercept IV Sensitive: B - Late Trials ziv-aflibercept IV Sensitive : B	ziv-aflibercept IV Sensitive: B - Late Trials ziv-aflibercept IV Sensitive : B